Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial

Overview of attention for article published in Diabetologia, April 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 25,794 followers.

Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomized trial https://t.co/BSgWR0azWS

RT @DiabetologiaJnl: Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomized trial ht…

Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomized trial https://t.co/BSgWR0azWS

Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomized trial https://t.co/BSgWR0azWS

Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial https://t.co/O3voCkPcHw